Catalent has launched its new OneXpress service for the integrated development, scale up and manufacturing of new oral solid dosage forms.   The OneXpress solution aims to accelerate a program’s transition from early-phase development to commercial-ready manufacturing leveraging Catalent’s phase-appropriate scale, technologies, oral dose form network and expertise to reduce risk, complexity and cost between phases. According to the company, by eliminating the need to transition projects betwee...